Gliclazide
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Non-insulin dependent diabetes mellitus.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Type 1 DM, diabetes complicated with ketoacidosis, hypersensitivity, severe renal and hepatic impairment. Pregnancy and lactation.Other Precaution to be observed while taking this medication
Diuretics and barbiturates may reduce the drug activity.
What are possible side effects of this medication ?
GI disturbances, skin reaction, leucopenia, thrombocytopenia, agranulocytosis, haemolytic anaemia, cholestatic jaundice, vomiting, diarrhoea, gastritis, increased transaminases.
Drug Category/Class
- Hypoglycemic Agents
- Antidiabetic Agents
- Sulfonylureas
- Blood Glucose Lowering Drugs, Excl. Insulins
- Drugs Used in Diabetes
- Alimentary Tract and Metabolism
- Cytochrome P-450 CYP2C9 Inhibitors
- Cytochrome P-450 CYP2C9 Inducers
- Cytochrome P-450 CYP2C19 Inducers
- Sulfonylureas
| Prescribed | For the treatment of NIDDM in conjunction with diet and exercise. |
| Weight : | 323.411 |
| Structure | Gliclazide |
 |
| Formula | C15H21N3O3S |
Gliclazide has 185 Brands listed
Search Generic Drugs alphabetically